Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort
Primary Purpose
Vaginal Discharge, Dyspareunia, Female Sexual Dysfunction
Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Tampon-like device for absorption of sexual fluids
Sponsored by
About this trial
This is an interventional treatment trial for Vaginal Discharge focused on measuring vaginal discharge, dripping, vaginal odor
Eligibility Criteria
Inclusion Criteria:
- Heterosexual
- Age 25-50
- Has used tampons in the past 5 years
- Sexually active (vaginal intercourse, minimum once per week)
- Answered "moderate" to "severe" to being bothered by dripping/discomfort on Patient Global Impression of Severity (PGI-S) questionnaire "on minutes, hours, or following day"
- Willing and able to use product
- Understands, reads, writes, and speaks English
Exclusion Criteria:
- Pregnant
- Currently using condoms
- Unable to use device due to poor motor function
- Chronic disease which makes prone to infection (diabetes, autoimmune)
- Recurrent yeast infections
- Recurrent Urinary tract infection (UTI) (>2 within the past year)
- Diagnosis of pelvic organ prolapse (Stage II or greater)
- Previous pelvic or vaginal surgery which, in the opinion of the investigator, may prevent proper use of product
- Unable to sign informed consent
Sites / Locations
- The Center for Specialized Women's Health, division of Garden State UrologyRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Immediate Use
1 hour use
Arm Description
Subjects in this arm will be instructed to use the study device for 2 minutes and remove
Subjects in this arm will be instructed to use the product for one hour and then remove
Outcomes
Primary Outcome Measures
Patient Global Impression of Improvement (PGI-I)
Validated Questionnaire
Weight of Investigational Device
Product weight (amount of fluid absorbed)
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04885556
Brief Title
Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort
Official Title
Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Unknown status
Study Start Date
April 5, 2021 (Actual)
Primary Completion Date
September 15, 2021 (Anticipated)
Study Completion Date
September 15, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Atlantic Health System
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Previous research has shown that semen deposition in the vagina after intercourse leads to dripping, discomfort, and vaginal odor. This study is evaluating a hygiene device designed to be inserted into the vagina after intercourse to absorb semen deposited into the vaginal canal to determine if there is a reduction in dripping and odor, and to determine the amount of fluids absorbed.
Detailed Description
Despite the significant number of sexual dysfunctions in women, physicians often avoid discussing these concerns in the office setting. With recent research on the role of the pelvic floor, and recently approved medical therapies for hypoactive sexual desire disorder, physicians have begun to adapt to questioning patients about libido and pain-related sexual dysfunctions. However, pain-related sexual questionnaires often focus on insertional and penetrational dyspareunia, without asking about discomfort minutes, hours, or even the day following sexual intercourse. One common compliant in ambulatory sexual medicine clinics is the bothersome dripping, odor, and discomfort women experience after sexual activity when no condom is used, and when intravaginal ejaculation occurs.
Previous studies have shown the effects of semen on alterations in the vaginal flora. These changes contribute to a multitude of clinical complaints and diagnoses, including malodor, continuous discharge after intercourse, and bacterial vaginosis (BV). The exposure of semen changes the vaginal flora by increasing the pH levels, in turn altering the bacterial growth pattern. This implies the persistent presence of semen in the vagina may be one of the causes of malodor and development of BV. Chvapil utilized gas chromatography and demonstrated that the longer period of time semen was present in the vagina, the more likely it resulted in a strong and unattractive vaginal odor. Gallo showed that an incidental diagnosis of BV was correlated with detection of sperm on gram stain, and frequent coitus with or without condom use.
The investigator's goal in this study is to evaluate a novel postcoital consumer health product and its effects on the complaints of continuous seepage of semen and vaginal odor after intercourse.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vaginal Discharge, Dyspareunia, Female Sexual Dysfunction, Vaginitis, Bacterial Vaginoses
Keywords
vaginal discharge, dripping, vaginal odor
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Subjects to be placed into one of two study groups, 1) immediate use and 2) 1 hour use
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Immediate Use
Arm Type
Experimental
Arm Description
Subjects in this arm will be instructed to use the study device for 2 minutes and remove
Arm Title
1 hour use
Arm Type
Experimental
Arm Description
Subjects in this arm will be instructed to use the product for one hour and then remove
Intervention Type
Device
Intervention Name(s)
Tampon-like device for absorption of sexual fluids
Intervention Description
Subjects will insert a tampon-like device to absorb sexual fluids after intercourse
Primary Outcome Measure Information:
Title
Patient Global Impression of Improvement (PGI-I)
Description
Validated Questionnaire
Time Frame
within 1 hour of use of product
Title
Weight of Investigational Device
Description
Product weight (amount of fluid absorbed)
Time Frame
within 1 hour of use of product
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Heterosexual
Age 25-50
Has used tampons in the past 5 years
Sexually active (vaginal intercourse, minimum once per week)
Answered "moderate" to "severe" to being bothered by dripping/discomfort on Patient Global Impression of Severity (PGI-S) questionnaire "on minutes, hours, or following day"
Willing and able to use product
Understands, reads, writes, and speaks English
Exclusion Criteria:
Pregnant
Currently using condoms
Unable to use device due to poor motor function
Chronic disease which makes prone to infection (diabetes, autoimmune)
Recurrent yeast infections
Recurrent Urinary tract infection (UTI) (>2 within the past year)
Diagnosis of pelvic organ prolapse (Stage II or greater)
Previous pelvic or vaginal surgery which, in the opinion of the investigator, may prevent proper use of product
Unable to sign informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Cynthia Evaniecki
Phone
973-537-5557
Email
cevaniecki@gsunj.com
Facility Information:
Facility Name
The Center for Specialized Women's Health, division of Garden State Urology
City
Denville
State/Province
New Jersey
ZIP/Postal Code
07834
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cynthia Evaniecki
Phone
973-537-5557
Email
cevaniecki@gsunj.com
Ext
Ingber
Email
mingber@gsunj.com
First Name & Middle Initial & Last Name & Degree
Michael Intber, MD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort
We'll reach out to this number within 24 hrs